Docoh
Loading...

OMI Owens & Minor

Filed: 3 Aug 21, 6:48am



Owens & Minor Reports 2nd Quarter Financial Results

    Record Q2 Earnings: GAAP EPS of $0.87 and Adjusted EPS of $1.06
    Revenue Growth of 38% year-over-year
    Affirms previously announced 2021 and 2022 guidance


RICHMOND, VA – August 3, 2021 – Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the second quarter of 2021, as summarized in the table below.

“We delivered a solid second-quarter, led by outstanding performance in both of our segments. Our results demonstrate the underlying strength of the Global Products segment, and another quarter of improved performance in the Global Solutions segment,” said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor. “Our business blueprint continues to be the framework that helps drive our results as we begin to return to a more typical operating environment and helps us to achieve our long-term financial targets.”

Pesicka added, “Our strong performance in the first half, and improved line of sight toward the remainder of 2021 allows us to maintain the range of our full-year guidance for adjusted EPS of $3.75 to $4.25 and adjusted EBITDA of $450 million to $500 million. In addition, we affirm our previously announced 2022 guidance.”

“I am immensely proud of what our teammates have accomplished as we continue to execute on our strategic priorities to deliver sustainable growth and value for all our stakeholders,” Pesicka concluded.


Financial Summary(1)
YTDYTD
($ in millions, except per share data)2Q212Q2020212020
Revenue$2,489$1,808$4,816$3,930
Operating Income, GAAP$96.9$22.2$243.6$33.0
Adj. Operating Income, Non-GAAP$115.5$38.9$278.2$66.3
Income (Loss) from continuing operations, GAAP$65.9$0.2$135.5($8.7)
Adj. Net Income, Non-GAAP$80.1$12.5$191.5$14.9
Adj. EBITDA, Non-GAAP$127.7$52.1$303.2$92.7
Income (Loss) from continuing operations per share, GAAP$0.87-$1.80($0.14)
Adj. Net income per share, Non-GAAP(2)
$1.06$0.20$2.54$0.24
(1) Financial results relate to continuing operations. Reconciliations of the differences between the non-GAAP financial measures presented in this release and their most directly comparable GAAP financial measures are included in the tables below.
(2) Adjusted net income per share, Non-GAAP for 2Q21 was unfavorably impacted as compared to prior year by foreign currency translation in the amount of $0.02 and, favorably impacted by $0.03 for the 2021 year-to-date period.



1



2nd Quarter 2021 Highlights

•    Substantial increase in year-over-year second quarter earnings driven by revenue growth, market dynamics, product mix, and operating efficiencies
o    117 basis point gross margin expansion
o    $77 million increase in adjusted operating income or 3 times the prior year
o    $10 million or 47% decrease in interest expense
o    Adjusted net income per share was over 5 times the prior year

•    38% Revenue growth year-over-year driven by:
o    Effective response to the ongoing recovery of elective procedures
o    Higher sales of PPE
o    Pass-through of elevated glove costs
o    Continued strong performance in our Patient Direct business

•    Balance Sheet
o    Total net debt at the end of the quarter was $964 million
o    Leverage ratio of net debt to trailing twelve-months adjusted EBITDA was 1.8 times

•    Business Highlights
o    Launched the non-profit Owens & Minor Foundation supported by a $10 million initial endowment, committed to building healthier communities by supporting trusted charitable and civic organizations
o    Released inaugural ESG report outlining the Company’s focus and contributions in the areas of empowering teammates, caring for customers and communities, operating responsibly, and ensuring environmental stewardship
o    Announced a seven-month electric truck pilot program with Penske Logistics and Penske Truck Leasing for large-scale deliveries to hospitals
o    Hosted an Investor Day in May outlining long-term strategy to drive sustainable growth targeting adjusted EBITDA in excess of $650 million and adjusted earnings per share of more than $6.00 by 2026
o    Received two prestigious supplier awards from Premier, Inc. for exemplary pandemic response:
2021 Supplier Legacy Award
COVID-19 Award for Most Supportive Supplier

Financial Outlook
The Company maintains its expectation of adjusted net income for 2021 to be in a range of $3.75 to $4.25 per share and adjusted EBITDA in the range of $450 million to $500 million. The Company also remains positioned to deliver its previously announced guidance for 2022.

Although the Company does provide guidance for adjusted net income per share and adjusted EBITDA (which are non-GAAP financial measures), it is not able to forecast the most directly comparable measures calculated and presented in accordance with GAAP without unreasonable effort. Certain elements of the composition of the GAAP amounts are not predictable, making it impracticable for the Company to forecast. Such elements include, but are not limited to restructuring and acquisition charges. As a result, no GAAP guidance or reconciliation of the Company’s adjusted net income per share guidance or adjusted EBITDA guidance is provided. For the same reasons, the Company is unable to assess the probable significance of the unavailable information, which could have a potentially significant impact on its future GAAP financial results. The outlook is based on certain assumptions that are subject to the risk factors discussed in the Company’s filings with the Securities and Exchange Commission (“SEC”).

Investor Conference Call for 2nd Quarter Financial Results
Owens & Minor executives will host a conference call at 8:30 a.m. EDT today, August 3, 2021, to discuss the results. Participants may access the call at 866-393-1604. The international dial-in number is 224-357-2191. A replay of the call will be available for one week by dialing 855-859-2056. The access code for the conference call, international dial-in and replay is 4479468. A webcast of the event will be available at www.owens-minor.com under the Investor Relations section.

Safe Harbor
This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This release contains certain ''forward-looking'' statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the statements in this release regarding our expectations with respect to our 2021 and 2022 financial performance and our 2026 financial targets, as well as other statements related to the impact of
2


COVID-19 on the Company’s results and operations and the Company’s expectations regarding the performance of its business. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Investors should refer to Owens & Minor’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC including the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and subsequent annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause the Company’s actual results to differ materially from its current estimates. These filings are available at www.owens-minor.com. Given these risks and uncertainties, Owens & Minor can give no assurance that any forward-looking statements will, in fact, transpire and, therefore, cautions investors not to place undue reliance on them. Owens & Minor specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services to deliver significant and sustained value across the breadth of the industry – from acute care to patients in their home. Aligned to its Mission of Empowering Our Customers to Advance HealthcareTM, more than 15,000 global teammates serve over 4,000 healthcare industry customers. A vertically-integrated, predominantly Americas-based footprint enables Owens & Minor to reliably supply its self-manufactured surgical and PPE products. This seamless value chain integrates with a portfolio of products representing 1,200 branded suppliers. Operating continuously since 1882 from its headquarters in Richmond, Virginia, Owens & Minor has grown into a FORTUNE 500 company with operations located across North America, Asia, Europe and Latin America. For more information about Owens & Minor, visit owens-minor.com, follow @Owens_Minor on Twitter and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.

Contact
Chandrika Nigam, Director, Investor Relations, Investor.Relations@owens-minor.com, 804-723-7556

SOURCE: Owens & Minor


3


Owens & Minor, Inc.
Consolidated Statements of Operations (unaudited)
(dollars in thousands, except per share data)
Three Months Ended June 30,
20212020
Net revenue$2,489,460 $1,807,719 
Cost of goods sold2,089,392 1,538,312 
Gross margin400,068 269,407 
Distribution, selling and administrative expenses294,096 241,734 
Acquisition-related and exit and realignment charges8,624 6,054 
Other operating expense (income), net464 (577)
Operating income96,884 22,196 
Interest expense, net11,540 21,605 
(Gain) loss on extinguishment of debt (1,856)
Other expense (income), net1,028 (2,696)
Income (loss) from continuing operations before income taxes84,316 5,143 
Income tax provision (benefit)18,420 4,982 
Income (loss) from continuing operations, net of tax65,896 161 
Loss from discontinued operations, net of tax (55,788)
Net income (loss)$65,896 $(55,627)
Basic income (loss) per common share:
Income (loss) from continuing operations$0.90 $— 
Loss from discontinued operations— (0.91)
Net income (loss)$0.90 $(0.91)
Diluted income (loss) per common share:
Income (loss) from continuing operations$0.87 $— 
Loss from discontinued operations— (0.91)
Net income (loss)$0.87 $(0.91)
4


Owens & Minor, Inc.
Consolidated Statements of Operations (unaudited)
(dollars in thousands, except per share data)
Six Months Ended June 30,
20212020
Net revenue$4,815,994 $3,930,412 
Cost of goods sold3,973,175 3,392,445 
Gross margin842,819 537,967 
Distribution, selling and administrative expenses586,796 495,782 
Acquisition-related and exit and realignment charges14,587 12,118 
Other operating expense (income), net(2,141)(2,886)
Operating income243,577 32,953 
Interest expense, net25,212 44,948 
(Gain) loss on extinguishment of debt40,433 2,271 
Other expense (income), net1,598 (1,977)
Income (loss) from continuing operations before income taxes176,334 (12,289)
Income tax provision (benefit)40,848 (3,541)
Income (loss) from continuing operations, net of tax135,486 (8,748)
Loss from discontinued operations, net of tax (58,203)
Net income (loss)$135,486 $(66,951)
Basic income (loss) per common share:
Income (loss) from continuing operations$1.87 $(0.14)
Loss from discontinued operations (0.96)
Net income (loss)$1.87 $(1.10)
Diluted income (loss) per common share:
Income (loss) from continuing operations$1.80 $(0.14)
Loss from discontinued operations (0.96)
Net income (loss)$1.80 $(1.10)
5


Owens & Minor, Inc.
Condensed Consolidated Balance Sheets (unaudited)
(dollars in thousands)
June 30,December 31,
20212020
Assets
Current assets
Cash and cash equivalents$45,424 $83,058 
Accounts receivable, net of allowances of $20,650 and $19,087738,573 700,792 
Merchandise inventories1,530,367 1,233,751 
Other current assets87,709 118,264 
Total current assets2,402,073 2,135,865 
Property and equipment, net of accumulated depreciation of $311,897 and $284,126306,511 315,662 
Operating lease assets174,952 144,755 
Goodwill389,864 394,086 
Intangible assets, net221,223 243,351 
Other assets, net97,206 101,920 
Total assets$3,591,829 $3,335,639 
Liabilities and equity
Current liabilities
Accounts payable$1,126,355 $1,000,186 
Accrued payroll and related liabilities96,081 109,447 
Other current liabilities212,741 236,094 
Total current liabilities1,435,177 1,345,727 
Long-term debt, excluding current portion1,007,968 986,018 
Operating lease liabilities, excluding current portion148,016 119,932 
Deferred income taxes45,327 50,641 
Other liabilities107,322 121,267 
Total liabilities2,743,810 2,623,585 
Total equity848,019 712,054 
Total liabilities and equity$3,591,829 $3,335,639 
6



Owens & Minor, Inc.
Consolidated Statements of Cash Flows (unaudited)
(dollars in thousands)
Six Months Ended June 30,
20212020
Operating activities:
Net income (loss)$135,486 $(66,951)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization45,501 48,804 
Share-based compensation expense13,040 7,814 
Loss on divestiture 65,472 
Loss on extinguishment of debt40,433 2,271 
Provision for losses on accounts receivable15,777 7,589 
Deferred income tax (benefit) expense(11,293)4,269 
Changes in operating lease right-of-use assets and lease liabilities826 (1,029)
Changes in operating assets and liabilities:
Accounts receivable(57,256)37,154 
Merchandise inventories(298,294)107,083 
Accounts payable127,473 16,395 
Net change in other assets and liabilities(3,363)(76,289)
Other, net4,076 (2,125)
Cash provided by operating activities12,406 150,457 
Investing activities:
Proceeds from divestiture 133,000 
Additions to property and equipment(14,630)(8,733)
Additions to computer software(4,051)(3,409)
Proceeds from sale of property and equipment22 69 
Proceeds from cash surrender value of life insurance policies 6,032 
Cash (used for) provided by investing activities(18,659)126,959 
Financing activities:
Proceeds from issuance of debt574,900 150,000 
Repayments under revolving credit facility(69,900)(47,900)
Repayments of debt(523,140)(258,005)
Financing costs paid(12,868)(10,367)
Cash dividends paid(364)(311)
Payment for termination of interest rate swaps(15,434)— 
Other, net(17,982)(4,479)
Cash used for financing activities(64,788)(171,062)
Effect of exchange rate changes on cash and cash equivalents(1,718)5,412 
Net (decrease) increase in cash, cash equivalents and restricted cash(72,759)111,766 
Cash, cash equivalents and restricted cash at beginning of period134,506 84,687 
Cash, cash equivalents and restricted cash at end of period (1)
$61,747 $196,453 
Supplemental disclosure of cash flow information:
Income taxes paid, net of refunds$68,030 $5,975 
Interest paid$17,768 $43,840 
(1) Restricted cash as of June 30, 2021 represents $16.3 million held in an escrow account as required by the Centers for Medicare & Medicaid Services (CMS) in conjunction with the Bundled Payments for Care Improvement (BPCI) initiatives.


7



Owens & Minor, Inc.
Summary Segment Information (unaudited)
(dollars in thousands)
Three Months Ended June 30,
20212020
% of % of
consolidatedconsolidated
Amountnet revenueAmount net revenue
Net revenue:
Segment net revenue
Global Solutions$1,977,579 79.44 %$1,548,639 85.67 %
Global Products688,568 27.66 %370,401 20.49 %
Total segment net revenue2,666,147 1,919,040 
Inter-segment revenue
Global Products(176,687)(7.10)%(111,321)(6.16)%
       Total inter-segment revenue(176,687)(111,321)
Consolidated net revenue$2,489,460 100.00 %$1,807,719 100.00 %
% of segment% of segment
Operating income:net revenuenet revenue
Global Solutions$18,470 0.93 %$(10,141)(0.65)%
Global Products95,327 13.84 %51,774 13.98 %
Inter-segment eliminations1,737 (2,772)
Intangible amortization(10,026)(10,611)
Acquisition-related and exit and realignment charges(8,624)(6,054)
Consolidated operating income$96,884 3.89 %$22,196 1.23 %
Depreciation and amortization:
Global Solutions$9,888 $11,065 
Global Products12,712 13,826 
Consolidated depreciation and amortization$22,600 $24,891 
Capital expenditures:
Global Solutions$6,024 $2,931 
Global Products6,034 2,135 
Discontinued operations 1,363 
Consolidated capital expenditures$12,058 $6,429 








8



Owens & Minor, Inc.
Summary Segment Information (unaudited)
(dollars in thousands)
Six Months Ended June 30,
20212020
% of % of
consolidatedconsolidated
Amountnet revenueAmount net revenue
Net revenue:
Segment net revenue
Global Solutions$3,827,088 79.47 %$3,396,233 86.41 %
Global Products1,347,318 27.98 %761,593 19.38 %
Total segment net revenue5,174,406 4,157,826 
Inter-segment revenue
Global Products(358,412)(7.45)%(227,414)(5.79)%
       Total inter-segment revenue(358,412)(227,414)
Consolidated net revenue$4,815,994 100.00 %$3,930,412 100.00 %
% of segment% of segment
Operating income:net revenuenet revenue
Global Solutions$27,362 0.71 %$(2,450)(0.07)%
Global Products258,915 19.22 %70,345 9.24 %
Inter-segment eliminations(8,061)(1,603)
Intangible amortization(20,052)(21,221)
Acquisition-related and exit and realignment charges(14,587)(12,118)
Consolidated operating income$243,577 5.06 %$32,953 0.84 %
Depreciation and amortization:
Global Solutions$19,727 $21,701 
Global Products25,774 27,103 
Consolidated depreciation and amortization$45,501 $48,804 
Capital expenditures:
Global Solutions$9,024 $3,963 
Global Products9,657 5,152 
Discontinued operations 3,027 
Consolidated capital expenditures$18,681 $12,142 







9



Owens & Minor, Inc.
Net Income (Loss) per Common Share (unaudited)
(dollars in thousands, except per share data)
Three Months Ended
 June 30,
Six Months Ended
 June 30,
2021202020212020
Income (loss) from continuing operations, net of tax$65,896 $161 $135,486 $(8,748)
Loss from discontinued operations, net of tax (55,788) (58,203)
Net income (loss)$65,896 $(55,627)$135,486 $(66,951)
Weighted average shares outstanding - basic72,818 61,12872,474 60,819
Dilutive shares2,987  2,791  
Weighted average shares outstanding - diluted75,805 61,128 75,265 60,819 
Basic income (loss) per common share:
Income (loss) from continuing operations$0.90 $— $1.87 $(0.14)
Loss from discontinued operations (0.91) (0.96)
Net income (loss)$0.90 $(0.91)$1.87 $(1.10)
Diluted income (loss) per common share:
Income (loss) from continuing operations$0.87 $— $1.80 $(0.14)
Loss from discontinued operations (0.91) (0.96)
Net income (loss)$0.87 $(0.91)$1.80 $(1.10)
























10



Owens & Minor, Inc.
GAAP/Non-GAAP Reconciliations (unaudited)
(dollars in thousands, except per share data)

The following table provides a reconciliation of reported operating income and income (loss) from continuing operations to non-GAAP measures used by management.
Three Months Ended
June 30,
Six Months Ended
June 30,
2021202020212020
Operating income, as reported (GAAP)$96,884 $22,196 $243,577 $32,953 
Intangible amortization (1)
10,026 10,611 20,052 21,221 
Acquisition-related and exit and realignment charges(2)
8,624 6,054 14,587 12,118 
Operating income, adjusted (non-GAAP) (Adjusted Operating Income)$115,534 $38,861 $278,216 $66,292 
Operating income as a percent of net revenue (GAAP)3.89 %1.23 %5.06 %0.84 %
Adjusted operating income as a percent of net revenue (non-GAAP)4.64 %2.15 %5.78 %1.69 %
Income (loss) from continuing operations, as reported (GAAP)$65,896 $161 $135,486 $(8,748)
Intangible amortization (1)
10,026 10,611 20,052 21,221 
Income tax (benefit) provision (6)
(2,411)430 (5,197)(2,831)
Acquisition-related and exit and realignment charges(2)
8,624 6,054 14,587 12,118 
Income tax (benefit) provision (6)
(2,073)245 (3,780)(1,616)
(Gain) loss on extinguishment of debt (3)
 (1,856)40,433 2,271 
Income tax benefit (6)
 (75)(10,477)(303)
Other (4)
570 (2,909)1,140 (2,331)
Income tax (benefit) provision (6)
(137)(118)(295)311 
Tax adjustment (5)
(402)— (402)(5,187)
Income from continuing operations, adjusted (non-GAAP) (Adjusted Net Income)$80,093 $12,543 $191,547 $14,905 
Income (loss) from continuing operations per diluted common share, as reported (GAAP)$0.87 $— $1.80 $(0.14)
Intangible amortization (1)
0.10 0.18 0.20 0.31 
Acquisition-related and exit and realignment charges(2)
0.09 0.10 0.14 0.17 
(Gain) loss on extinguishment of debt (3)
 (0.03)0.40 0.03 
Other (4)
0.01 (0.05)0.01 (0.04)
Tax adjustment (5)
(0.01)— (0.01)(0.09)
Income from continuing operations per diluted common share, adjusted (non-GAAP) (Adjusted EPS)$1.06 $0.20 $2.54 $0.24 










11



Owens & Minor, Inc.
GAAP/Non-GAAP Reconciliations (unaudited), continued
(dollars in thousands, except per share data)

The following tables provide reconciliations of net income (loss) and total debt to non-GAAP measures used by management.

Three Months Ended
June 30,
Six Months Ended
June 30,
Trailing Twelve Months Ended
June 30, 2021
2021202020212020
Net income (loss), as reported (GAAP)$65,896 $(55,627)$135,486 $(66,951)$232,308 
Loss from discontinued operations, net of tax 55,788  58,203  
Income tax provision (benefit)18,420 4,982 40,848 (3,541)66,223 
Interest expense, net11,540 21,605 25,212 44,948 63,663 
Intangible amortization (1)
10,026 10,611 20,052 21,221 40,320 
Other depreciation and amortization (7)
12,575 13,492 25,448 26,793 50,501 
EBITDA (non-GAAP)118,457 50,851 247,046 80,673 453,015 
Acquisition-related and exit and realignment charges (2)
8,624 6,054 14,587 12,118 40,221 
(Gain) loss on extinguishment of debt (3)
 (1,856)40,433 2,271 49,381 
Other (4)
570 (2,909)1,140 (2,331)2,285 
EBITDA, adjusted (non-GAAP) (Adjusted EBITDA)$127,651 $52,140 $303,206 $92,731 $544,902 

June 30,
2021
Total debt, as reported (GAAP)$1,009,036 
Cash and cash equivalents45,424 
Net debt (non-GAAP)$963,612 
Trailing twelve-months EBITDA, adjusted (non-GAAP) (Adjusted EBITDA)544,902 
Leverage ratio of net debt to trailing twelve-months adjusted EBITDA1.8 
















12


Owens & Minor, Inc.
GAAP/Non-GAAP Reconciliations (unaudited), continued

The following items have been excluded in our non-GAAP financial measures:

(1) Intangible amortization includes amortization of intangible assets established during purchase accounting for business combinations. These amounts are highly dependent on the size and frequency of acquisitions and are being excluded to allow for a more consistent comparison with forecasted, current and historical results and the results of our peers.
(2) There were no acquisition-related charges for the three and six months ended June 30, 2021 compared to $3.9 million and $8.1 million for the same periods of 2020, which consisted primarily of transition costs for the Halyard acquisition. Acquisition-related charges for the twelve months ended June 30, 2021 were $3.7 million, which consisted primarily of transition costs for the Halyard acquisition. Exit and realignment charges were $8.6 million and $14.6 million for the three and six months ended June 30, 2021 and consisted primarily of an increase in reserves associated with certain retained assets of Fusion5, IT restructuring charges and other costs related to the reorganization of our U.S. operations. Exit and realignment charges were $2.2 million and $4.0 million for the three and six months ended June 30, 2020 and consisted primarily of severance from reduction in force and other costs related to the reorganization of the U.S. commercial, operations and executive teams. Exit and realignment charges were $36.5 million for the twelve months ended June 30, 2021, which were associated with severance from reduction in workforce, restructuring charges related to our client engagement center, IT restructuring charges, loss on sale of certain Fusion5 assets, and other costs related to the reorganization of the U.S. operations and commercial teams.
(3) Loss on extinguishment of debt for the six months ended June 30, 2021 includes the write-off of deferred financing costs and third party fees associated with the debt financing in March 2021 of $15.3 million and amounts reclassified from accumulated other comprehensive loss as a result of the termination of our interest rate swaps of $25.1 million. (Gain) loss on extinguishment of debt for the three and six months ended June 30, 2020 primarily includes the write-off of deferred financing costs and third party fees, offset by the gain on extinguishment of debt related to the partial repurchase of our 2021 and 2024 Notes. Loss on extinguishment of debt for the twelve months ended June 30, 2021 includes the write-off of deferred financing costs and third party fees of $19.3 million, amounts reclassified from accumulated other comprehensive loss as a result of the termination of our interest rate swaps of $25.1 million, and a make-whole premium related to the extinguishment of our 2021 Notes of $5.0 million.
(4) Other includes interest costs and net actuarial losses related to our retirement plans for the three and six months ended June 30, 2021 and the twelve months ended June 30, 2021. Other includes interest costs and net actuarial losses related to our retirement plans of $0.6 million and $1.2 million for the three and six months ended June 30, 2020 and gain from the surrender of company-owned life insurance policies of $(3.5) million for the three and six months ended June 30, 2020.
(5) Includes tax adjustments associated with the estimated benefits under the Tax Cuts and Jobs Act and the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
(6) These charges have been tax effected in the preceding table by determining the income tax rate depending on the amount of charges incurred in different tax jurisdictions and the deductibility of those charges for income tax purposes.
(7) Other depreciation and amortization includes depreciation expense for property and equipment and amortization for capitalized computer software.         

Use of Non-GAAP Measures

This earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP").  In general, the measures exclude items and charges that (i) management does not believe reflect Owens & Minor, Inc.'s (the "Company") core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends.  Management uses these non-GAAP financial measures internally to evaluate the Company's performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation.

Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on its financial and operating results and in comparing the Company's performance to that of its competitors.  However, the non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

The non-GAAP financial measures disclosed by the Company should not be considered substitutes for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated.
13